Search

Search Results
Results 7341 - 7350 of 17271 for Active treatment
  • Drug - 17 Jun 2026
    Consumer Medicine Information (CMI) about Bylvay intended for persons living in Australia.
  • Drug - 17 Jun 2026
    Consumer Medicine Information (CMI) about Pluvicto intended for persons living in Australia.
  • Drug - 17 Jun 2026
    Consumer Medicine Information (CMI) about Retevmo Tablets intended for persons living in Australia.
  • News - 16 Jun 2026
    Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, fueling drug resistance and disease progression.
  • News - 15 Jun 2026
    Scientists have long known that being obese increases the risk of dementia and Alzheimer's disease. What remains unclear is how that risk develops in the brain.
  • News - 15 Jun 2026
    A study by the University of Barcelona has discovered why the two main types of lung cancer — adenocarcinoma of the lung and squamous cell carcinoma — respond differently to anti-angiogenic therapy,...
  • News - 15 Jun 2026
    A detailed cellular study of Crohn’s disease has mapped how gene activity changes across more than 50 cell types in the gut.
  • News - 15 Jun 2026
    Researchers from ETH Zurich have developed a molecular switch that is controlled by light. It wakes lung cancer cells up from a protective dormant state so that they are more accessible for treatment.
  • Drug - 12 Jun 2026
    Consumer Medicine Information (CMI) about Saphnelo intended for persons living in Australia.
  • Drug - 12 Jun 2026
    Consumer Medicine Information (CMI) about Salofalk Granules intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.